Cosponsor
Sign in

HR 1082 · in committee · significant

Shandra Eisenga Human Cell and Tissue Product Safety Act

What this bill does

  • This bill establishes civil penalties for violations of FDA rules on donating and handling human cells and tissues.
  • It affects the FDA, healthcare providers, tissue manufacturers, and people who donate or receive cell and tissue products.
  • The FDA must conduct workshops, create a public comment process, and publish annual reports on tissue product regulation.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

  1. 01

    How might civil penalties for FDA rule violations change the current practices of tissue manufacturers and healthcare providers?

  2. 02

    What specific safety gaps in human cell and tissue handling does this bill attempt to address through new FDA oversight?

  3. 03

    How could the costs of compliance with these penalties be passed along to patients who receive cell and tissue products?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · R-MI-2

John R. Moolenaar

Citizen cosponsors

0

In Congress

1/ 435

House Reps cosponsoring

Introduced 2025-06-24

Joining the bill

Legislative timeline

  1. 2025-06-24 · senate · IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  2. 2025-06-23 · house · Floor

    Motion to reconsider laid on the table Agreed to without objection.

  3. 2025-06-23 · house · Floor

    On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)

  4. 2025-06-23 · Floor

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)

  5. 2025-06-23 · house · Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.

  6. 2025-06-23 · house · Floor

    Considered under suspension of the rules. (consideration: CR H2860-2862)

  7. 2025-06-23 · house · Floor

    Mr. Bilirakis moved to suspend the rules and pass the bill.

  8. 2025-06-12 · house · Calendars

    Placed on the Union Calendar, Calendar No. 127.

  9. 2025-06-12 · house · Committee

    Reported by the Committee on Energy and Commerce. H. Rept. 119-160.

  10. 2025-06-12 · Committee

    Reported by the Committee on Energy and Commerce. H. Rept. 119-160.

  11. 2025-04-29 · house · Committee

    Ordered to be Reported by Voice Vote.

  12. 2025-04-29 · house · Committee

    Committee Consideration and Mark-up Session Held

  13. 2025-02-06 · house · IntroReferral

    Referred to the House Committee on Energy and Commerce.

  14. 2025-02-06 · IntroReferral

    Introduced in House

  15. 2025-02-06 · IntroReferral

    Introduced in House

Congress.gov ↗

Citizen comments

Sign in to comment on this bill.

No comments yet — be the first.